Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Deep Medicine Acquisition...

    NASDAQ: DMAQ · Real-Time Price · USD
    2.96
    -5.43 (-64.72%)
    At close: Jan 31, 2024, 10:00 PM

    Deep Medicine Acquisition Statistics

    Share Statistics

    Deep Medicine Acquisition has 4.36M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 4.36M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 501.86K

    Failed to Deliver (FTD) Shares

    n/a
    		 245

    FTD / Avg. Volume

    n/a
    		 1.72%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -61.38 and the forward PE ratio is null. Deep Medicine Acquisition's PEG ratio is -0.2.

    PE Ratio

    n/a
    		 -61.38

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 9.62

    P/FCF Ratio

    n/a
    		 -23.7

    PEG Ratio

    n/a
    		 -0.2
    Financial Ratio History

    Enterprise Valuation

    Deep Medicine Acquisition has an Enterprise Value (EV) of 25.84M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -6.47

    EV / EBIT

    n/a
    		 -24.93

    EV / FCF

    n/a
    		 -24.93

    Financial Position

    The company has a current ratio of 3.5, with a Debt / Equity ratio of 0.73.

    Current Ratio

    n/a
    		 3.5

    Quick Ratio

    n/a
    		 3.5

    Debt / Equity

    n/a
    		 0.73

    Debt / EBITDA

    n/a
    		 -0.47

    Debt / FCF

    n/a
    		 -1.8

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -15.67% and Return on Invested Capital is -9.06%.

    Return on Equity

    n/a
    		 -15.67%

    Return on Assets

    n/a
    		 -4.09%

    Return on Invested Capital

    n/a
    		 -9.06%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-200,116

    Employee Count

    n/a
    		 2

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 57.57K

    Effective Tax Rate

    n/a
    		 -16.8%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0.02, so Deep Medicine Acquisition's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.02

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 10.76

    200-Day Moving Average

    n/a
    		 11.2

    Relative Strength Index (RSI)

    n/a
    		 15.43

    Average Volume (20 Days)

    n/a
    		 14,214

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -60K

    Operating Income

    n/a
    		 -342.66K

    Net Income

    n/a
    		 -400.23K

    EBITDA

    n/a
    		 -3.99M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.17
    Full Income Statement

    Balance Sheet

    The company has 595.54K in cash and 1.86M in debt, giving a net cash position of -1.27M.

    Cash & Cash Equivalents

    n/a
    		 595.54K

    Total Debt

    n/a
    		 1.86M

    Net Cash

    n/a
    		 -1.27M

    Retained Earnings

    n/a
    		 -6.44M

    Total Assets

    n/a
    		 6.88M

    Working Capital

    n/a
    		 3.18M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.04M and capital expenditures 0, giving a free cash flow of -1.04M.

    Operating Cash Flow

    n/a
    		 -1.04M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -1.04M

    FCF Per Share

    n/a
    		 -0.45
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DMAQ does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -1.63%

    FCF Yield

    n/a
    		 -4.22%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for DMAQ.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.19

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist